Shannon Faught Honored as a MM+M 2025 Woman of Distinction
Alora Pharmaceuticals is proud to announce that Shannon Faught, the Chief Commercial Officer, was recognized as a 2025 Woman of Distinction by Medical Marketing & Media (MM+M). This prestigious honor celebrates women executives in healthcare marketing who have made significant contributions to the industry over the last year, marking the 10th anniversary of the Women of Distinction program.
Celebrating Impactful Leadership
With more than 20 years in the pharmaceutical sector, Shannon Faught stands out as a leader adept in commercial strategy and revenue generation. Her role focuses on guiding Alora's product launch processes and commercialization strategies. She prides herself on maximizing brand potential and ensuring the success of new products in the market, a testament to her dedication to her work and the industry.
Quotes from Alora's CEO
Art Deas, CEO of Alora Pharmaceuticals, expresses admiration for Shannon, stating, "Shannon is an exceptional leader whose strategic vision, integrity, and relentless focus on execution have made a lasting impact on Alora and the patients we serve." He further underscores her impressive leadership attributes, claiming she inspires those around her with a blend of empathy and insight. Her recognition as the 2024 recipient of the Alora Excellence in Leadership Award aligns perfectly with her recent accolade from MM+M.
Women Leading in the Medical Marketing Field
Lecia Bushak, editor of pharma at MM+M, reflects on the significance of celebrating women in medical marketing for a decade. She notes that women have been at the forefront of driving creativity and innovation within the industry, significantly shaping healthcare's future. The 2025 Women of Distinction honorees will be recognized for their remarkable contributions and accomplishments as part of the upcoming awards ceremony.
Event Details for Honorees
The MM+M Women of Distinction event is set to take place, gathering talented women leaders for a celebration of their achievements. This event will also highlight the accomplishments of the 2025 classes, which includes both Women of Distinction and Women to Watch categories, promoting the importance of women in leadership roles.
About Alora Pharmaceuticals
Alora Pharmaceuticals, LLC operates as a parent company to a range of specialty pharmaceutical entities. Headquartered in Alpharetta, Georgia, Alora encompasses a family of companies, including Avion Pharmaceuticals, Acella Pharmaceuticals, Osmotica Pharmaceuticals, Sovereign Pharmaceuticals, Trigen Laboratories, and Vertical Pharmaceuticals. Together, they contribute to advancing healthcare solutions and enhancing patient care.
About MM+M
MM+M (Medical Marketing + Media) serves as the leading source of information for pharmaceutical marketing, offering up-to-date insights, analyses, and best practices in the industry. Since its inception in 1966, MM+M has become essential reading for healthcare marketers, providing valuable content that helps stakeholders navigate the evolving landscape of medical marketing.
Frequently Asked Questions
Who is Shannon Faught?
Shannon Faught is the Chief Commercial Officer at Alora Pharmaceuticals, responsible for commercial strategy and product launches.
What is the MM+M Women of Distinction program?
This program recognizes outstanding female leaders in healthcare marketing who have significantly influenced their organizations and the industry over the past year.
When will the honorees be celebrated?
The honorees will be celebrated in an event scheduled for June 3, 2025.
What does Alora Pharmaceuticals do?
Alora Pharmaceuticals, LLC is a parent company to several specialty pharmaceutical entities, focusing on enhancing healthcare solutions.
How long has MM+M been recognized in the industry?
MM+M has been a trusted resource for pharmaceutical marketing information since 1966.
